Journals / Ağrı / 2012 / Cilt: 24 - Sayı: 3

Evaluation of platelet serotonin levels in migraine without aura

Aurasız migrende trombosit serotonin düzeylerinin değerlendirilmesi

Journal
Ağrı
Pages
117–122
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Our results suggest that migraineurs have significantly low platelet serotonin concentration compared to controls.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The relation between migraine and serotonin levels is not clear.
📊
Key Findings & Data:Methods: Thirty female migraine without aura patients who were diagnosed according to the criteria of the International Headache Society and 20 healthy controls were enrolled in the study.
💡
Conclusion & Impact:Results: Our results suggest that migraineurs have significantly low platelet serotonin concentration compared to controls.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: The relation between migraine and serotonin levels is not clear. Plasma serotonin levels in migraineurs were investigated in previous studies. However, in the current literature, it is stated that measurement of serotonin level in platelets is more reliable. Methods: Thirty female migraine without aura patients who were diagnosed according to the criteria of the International Headache Society and 20 healthy controls were enrolled in the study. The Hamilton depression scale (HAM-D) was applied to all subjects and those scoring 10 and above were not considered. Fasting venous blood samples were taken from subjects in the morning. Platelet rich and poor plasma were prepared. The samples were measured with high performance liquid chromatography and platelet serotonin concentration was calculated. Results: Our results suggest that migraineurs have significantly low platelet serotonin concentration compared to controls. The ratio of family history of migraine in the patient group was clearly higher than in controls. HAM-D scores were significantly higher in migraineurs than in the control group. Although there was a weak correlation between low serotonin levels and attack duration and number, there was no statistical significance. Conclusion: Our results suggest the role of heredity and low serotonin levels in the migraine pathogenesis. Even though all subjects enrolled in the study had scores under the depression level, HAM-D scores were higher in migraineurs than controls. This may indicate the presence of subclinical depression associated with low serotonin levels in migraineurs. Extensive studies including both serotonin and other markers during pain and pain-free periods are needed.

Özet

Amaç: Migren ile serotonin düzeyleri arasındaki ilişki net değildir. Daha önceki çalışmalarda migrenlilerde plazma serotonin düzeyleri araştırılmıştır. Ancak, güncel literatürde santral sinir sistemindeki düzeyi yansıtması açısından trombositlerdeki serotonin düzeyinin daha güvenilir sonuçlar vereceği belirtilmektedir. Gereç ve Yöntem: Çalışma Uluslararası Başağrısı Derneği’nin ölçütlerine göre tanı almış 30 aurasız migrenli kadın hasta ile yaş ve cinsiyet olarak uyumlu 20 sağlıklı kontrolle gerçekleştirildi. Tüm hasta ve kontrollere Hamilton depresyon ölçeği (HAM-D) uygulandı ve 10 puanın üzerinde alanlar çalışmaya alınmadı. Olgulardan sabah açlık venöz kan örnekleri alındı. Trombositten zengin ve fakir plazma hazırlanarak yüksek performanslı sıvı kromatografisi cihazında değerlendirildi ve trombosit serotonin konsantrasyonu hesaplandı. Bulgular: Çalışmamızda migrenlilerin trombosit serotonin konsantrasyonunu kontrol gurubuna göre istatistiksel olarak anlamlı düzeyde düşük olduğu saptandı. Hasta grubunda ailede migren görülme oranı kontrol grubundan belirgin oranda yüksek bulundu. Migrenlilerin HAM-D puanları kontrol grubundan belirgin düzeyde yüksek bulundu. Atak sayısı ve süresi ile düşük serotonin düzeyleri arasında zayıf bir korelasyon görülse de istatiksel olarak anlamlı bir ilişki saptanmadı. Sonuç: Sonuçlarımız migren patojenezinde düşük serotonin düzeylerine ve migrende kalıtımın rolüne işaret etmektedir. Çalışmaya alınan tüm olgular klinik depresyon puanının altında seçilmiş olmalarına rağmen, migrenlilerde kontrollere göre HAM-D puanları daha yüksek bulunmuştur. Bu durum migrenlilerde düşük serotonin düzeyi ile ilişkili subklinik depresyonun varlığına işaret edebilir. Hem ağrılı hem de ağrısız dönemleri içeren ve serotonin dışında da belirteçleri kapsayan geniş ölçekli çalışmalara ihtiyaç vardır.

🔖

Cite This Article

AYALP, S., ŞAHİN, Ş., AKSUNGAR, F. B., KARŞIDAĞ, S. (2012). Evaluation of platelet serotonin levels in migraine without aura. Ağrı, Cilt: 24 - Sayı: 3, 117–122. https://ajindex.com/articles/174946

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Goadsby PJ, Lipton RB, Ferrari MD. Migraine-current understanding and treatment. N Engl J Med 2002;346(4):257-70
  2. Lipton RB, Steward WF, Diamond S. Prevalence and burden of migraine in US: Data from the American Migraine Study II. Headache 2001;41(7)646-57
  3. Izzati-Zade KF. The role of serotonin in the pathogenesis and clinical presentations of migraine attacks. Neurosci Behav Physiol 2008;38(5):501-5
  4. Arulmozhi DK, Veeranjaneyulu A, Bodhankar SL. Migraine: current concepts and emerging therapies. Vascul Pharmacol 2005;43(3):176-87
  5. Boes CJ, Capobianco DJ, Cutrer FM, Dodick DW, Garza I, Swanson JW. Headache and other craniofacial pain. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, editors. Neurology in clinical practice. 2nd. ed. Philadelphia: Butterworth- Heinemann; 2004. p. 2072-90
  6. Ulrich V, Gervil M, Kyvik KO, Olesen J, Russell MB. Evidence of a genetic factor in migraine with aura: a population-based Danish twin study. Ann Neurol 1999;45(2):242-6
  7. Tfelt-Hansen PC. History of migraine with aura and cortical spreading depression from 1941 and onwards. Cephalalgia 2010;30(7):780-92
  8. Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KM. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology 2003;60(8):1308- 12
  9. Nagata E, Shibata M, Hamada J, Shimizu T, Katoh Y, Gotoh K, et al. Plasma 5-hydroxytryptamine (5-HT) in migraine during an attack-free period. Headache 2006;46(4):592-6
  10. Cassidy EM, Tomkins E, Dinan T, Hardiman O, O’Keane V. Central 5-HT receptor hypersensitivity in migraine without aura. Cephalalgia 2003;23(1):29-34
  11. Jans LA, Riedel WJ, Markus CR, Blokland A. Serotonergic vulnerability and depression: assumptions, experimental evidence and implications. Mol Psychiatry 2007;12(6):522- 43
  12. Panconesi A, Sicuteri R. Headache induced by serotonergic agonists--a key to the interpretation of migraine pathogenesis? Cephalalgia 1997;17(1):3-14
  13. Matsunaga M, Murakami H, Yamakawa K, Isowa T, Kasugai K, Yoneda M, et al. Genetic variations in the serotonin transporter gene-linked polymorphic region influence attraction for a favorite person and the associated interactions between the central nervous and immune systems. Neurosci Lett 2010:14;468(3):211-5
  14. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24 Suppl 1:9- 160
  15. Bendtsen L, Jensen R, Hindber